Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-a]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity
Mohamed H. Attia, Deena S. Lasheen, Nermin Samir, Azza T. Taher, Hatem A. Abdel-Aziz, Dalal A. Abou El Ella · 2024
Read Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-a]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity by Mohamed H. Attia, Deena S. Lasheen, Nermin Samir, Azza T. Taher, Hatem A. Abdel-Aziz, Dalal A. Abou El Ella (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678221.txt.
Description
Mohamed Attia and co-authors design, in 2024, drug candidates that block two cancer-related enzymes at once. Blocking both a cell-cycle enzyme and a growth receptor enzyme could slow tumors that resist single drugs. The team synthesized two dozen compounds in a fused ring family and tested them in enzyme assays.
Two compounds stood out, matching approved reference drugs closely on the cell-cycle enzyme and showing solid activity on the second. One other compound hit many cancer cell lines in a national screening panel. Computer docking explored how the active compounds sit in their targets. The authors present the family as a lead for dual-target cancer drugs.
Catalog record
| CREATOR | Mohamed H. Attia, Deena S. Lasheen, Nermin Samir, Azza T. Taher, Hatem A. Abdel-Aziz, Dalal A. Abou El Ella |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 70 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |